Global Blood Therapeutics, Inc. EBITDA Margin 2015-2022 | GBT
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Global Blood Therapeutics, Inc. (GBT) over the last 10 years. The current EBITDA margin for Global Blood Therapeutics, Inc. as of June 30, 2022 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2022-06-30 | $0.24B | $-0.29B | -123.40% |
| 2022-03-31 | $0.21B | $-0.28B | -133.18% |
| 2021-12-31 | $0.20B | $-0.28B | -143.08% |
| 2021-09-30 | $0.18B | $-0.25B | -141.11% |
| 2021-06-30 | $0.17B | $-0.25B | -149.09% |
| 2021-03-31 | $0.15B | $-0.23B | -155.03% |
| 2020-12-31 | $0.12B | $-0.23B | -187.90% |
